Franklin Resources
HRMY icon

Franklin Resources’s Harmony Biosciences HRMY Stock Holding History

Franklin Resources’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.03M Buy
193,131
+4,991
+3% +$157K ﹤0.01% 1425
2026
Q1 		$5.27M Buy
188,140
+141,794
+306% +$4.65M ﹤0.01% 1499
2025
Q4 		$1.73M Sell
46,346
-618
-1% -$20.3K ﹤0.01% 1858
2025
Q3 		$1.29M Buy
46,964
+14,579
+45% +$502K ﹤0.01% 1970
2025
Q2 		$1.02M Buy
32,385
+1,745
+6% +$56.1K ﹤0.01% 1986
2025
Q1 		$1.02M Sell
30,640
-1,229
-4% -$44.1K ﹤0.01% 1963
2024
Q4 		$1.1M Buy
31,869
+2,096
+7% +$72K ﹤0.01% 1955
2024
Q3 		$1.06M Buy
29,773
+1,720
+6% +$60.4K ﹤0.01% 1960
2024
Q2 		$846K Buy
28,053
+2,992
+12% +$90K ﹤0.01% 2002
2024
Q1 		$842K Sell
25,061
-2,075
-8% -$66.6K ﹤0.01% 2020
2023
Q4 		$876K Buy
+27,136
New +$757K ﹤0.01% 1699

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's HRMY Position: Q2 2026 in Review

Franklin Resources increased its Harmony Biosciences (HRMY) stake by 2.7% in Q2 2026, buying an estimated $157K and bringing the position to 193,131 shares worth $7.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

Franklin Resources first reported a position in HRMY in Q4 2023 and has held it in 11 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Franklin Resources held 193,131 shares of Harmony Biosciences worth $7.03M as of Q2 2026.
  • Franklin Resources bought 4,991 Harmony Biosciences shares in Q2 2026, an estimated $157K.
  • Harmony Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1425 holding.
  • Franklin Resources first reported a position in Harmony Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.